Description

(Immunomodulatory Peptide for Immune Optimization, Antiviral Defense, and Cellular Repair)

Clinically Proven Immune Enhancer for Resilience, Infection Recovery, and Chronic Inflammation Support

Thymosin Alpha-1 (Tα1) is a synthetic peptide fragment of the naturally occurring thymic hormone thymosin, recognized for its powerful role in immune modulation, antiviral defense, and inflammation regulation. This 300 mcg/mL injectable formulation in a 5 mL sterile vial offers a high-purity, preservative-free solution for subcutaneous administration under medical supervision.

Thymosin Alpha-1 has been studied extensively across clinical settings, including in chronic infections, autoimmune conditions, cancer immunotherapy, and immunosenescence in aging populations. It works by enhancing both innate and adaptive immunity, improving the function of T-cells, natural killer (NK) cells, and dendritic cells, while also promoting anti-inflammatory cytokine balance.

Product Details

• Peptide: Thymosin Alpha-1 (Tα1)

• Concentration: 300 mcg/mL

• Total Volume: 5 mL (1,500 mcg total per vial)

• Formulation: Sterile, preservative-free injectable solution

• Route: Subcutaneous injection

• Storage: Store refrigerated at 2–8°C (36–46°F)

• Shelf Life (After Opening): Use within 30 days of reconstitution or puncture

• Use: Physician-guided therapeutic or preventative immune therapy

What Is Thymosin Alpha-1?

Thymosin Alpha-1 is a 28-amino acid peptide fragment originally isolated from the thymus gland. It plays a central role in immune function by promoting T-cell differentiation, enhancing pathogen clearance, and modulating cytokine responses. Unlike general immune boosters, Tα1 functions as an immune normalizer—enhancing immune activity when needed, and calming overactivation in autoimmune or chronic inflammatory states.

Approved in over 30 countries (outside the U.S.) for treatment of viral hepatitis, immunodeficiency, and cancer-related immune suppression, it is now widely used in integrative and functional medicine for a variety of chronic conditions and immune-challenged patients.

Mechanism of Action

Thymosin Alpha-1 supports immune resilience through multiple biological pathways:

• Promotes T-cell maturation and function—crucial for adaptive immunity

• Activates dendritic cells and antigen presentation

• Enhances natural killer (NK) cell cytotoxicity

• Regulates cytokine release to reduce excessive inflammation

• Supports intracellular viral defense by upregulating interferon and MHC class I expression

These effects collectively result in improved immune coordination, pathogen clearance, and tissue protection from chronic immune activation or infection.

Clinical and Functional Applications

1. Antiviral Therapy & Infection Defense

• Used in chronic viral infections such as Hepatitis B/C, EBV, and Lyme disease

• Beneficial in post-viral fatigue and Long COVID syndromes

• May reduce viral load and enhance antibody response in vulnerable patients

2. Immune Resilience & Prevention

• Enhances immune readiness in patients undergoing surgery, chemotherapy, or travel to high-risk areas

• Effective during cold and flu season or for immune-compromised individuals

3. Autoimmune & Chronic Inflammatory Conditions

• Helps regulate overactive immune responses in autoimmunity without full suppression

• Reduces flares and improves tissue-level immune tolerance

4. Healthy Aging and Immune Decline

• Mitigates immune senescence in aging adults

• Improves vaccination response and cellular defense in elderly or immunocompromised individuals

5. Adjunctive Cancer Therapy (Investigational Use)

• Supports immune surveillance during chemo or radiation

• Used in some protocols for melanoma, lung cancer, and lymphoma (off-label)

Dosing and Administration

• Typical Dose: 750 mcg to 1.5 mg per week (divided into 2–3 doses)

• Administration Route: Subcutaneous injection in the abdomen or thigh

• Cycle: 4–12 weeks per phase, with clinical reevaluation

• Frequency: 2–3 times per week is typical; may vary by condition and severity

Always follow a personalized dosing plan created by a licensed healthcare provider.

Safety and Tolerability

Thymosin Alpha-1 has an excellent safety profile, with no known toxicity, immunosuppression, or long-term complications when used as directed.

Mild, self-limiting side effects may include:

• Injection site redness or tenderness

• Mild fatigue or headache in initial doses

• Rare allergic reaction (especially in those sensitive to peptides)

Compatible with most medications, including antivirals, immunotherapies, and vaccines.

Contraindications

Avoid or use with caution in:

• Pregnant or breastfeeding individuals (unless directed by physician)

• Individuals with known hypersensitivity to peptide-based therapies

Regular monitoring may be advised in oncologic or immunocompromised patients receiving other immune therapies.

Storage & Handling

• Store refrigerated at 2–8°C (36–46°F)

• Protect from direct sunlight and contamination

• Use aseptic technique during each dose withdrawal

• Use within 30 days of first use

Why Choose Thymosin Alpha-1?

• Clinically validated in immune dysfunction, infection, and immunosenescence

• Acts as an immune balancer—not just a stimulator

• Excellent for long-term immune system support and resilience

• Integrates well with peptide stacks including BPC-157, NAD+, and Semax/Selank

Summary

Thymosin Alpha-1 – 300 mcg/mL, 5 mL Vial offers a modern, evidence-based approach to immune strengthening, inflammation control, and infection recovery. Whether used as a standalone immune modulator or integrated into a larger functional medicine or longevity protocol, this peptide is a cornerstone in the growing field of precision immune therapy—offering safety, adaptability, and clinical impact where conventional treatments fall short.